导师姓名：吴晓萍
性别：女
人气指数：40

所属院校：暨南大学
所属院系：生命科学技术学院
职称：研究员
导师类型：博导
招生专业：
研究领域： 一直致力于细胞因子与创伤修复、肿瘤的基础理论、临床应用及其相关基因工程药物的研发
研究领域： 一直致力于细胞因子与创伤修复、肿瘤的基础理论、临床应用及其相关基因工程药物的研发 [收起]




通讯方式 :
电子邮件：twxp@jnu.edu.cn


个人简述 :
近3年主持国家及省部级项目5项。近5年来在国际期刊上发表SCI论文20多篇，其中以第一作者（或通讯作者）在A1类刊物发表5篇，在A2类刊物发表10篇。获国家科学技术发明二等奖1项、广东省科学技术发明一等奖1项和中华医学科技奖一等奖1项。获发明专利2项，参编著作2部。2010年被评为广东省高等学校“千百十工程”省级培养对象。

科研工作 :
[1] Jianzhang Wu, Shoubiao Wu, Lingyi Shi, Shanshan Zhang, Jiye Ren, Song Yao, Di Yun, Lili Huang, Jiabing Wang, Wulan Li*, Xiaoping Wu*, Peihong Qiu, Guang Liang*. Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer. European Journal of Medicinal Chemistry. 2017, 125: 1321-1331. [2] Xiaomian Lin, Li Song, Dan He, Xiangfeng Zeng, Jianzhang Wu, Wu Luo1, Qi Yang, Jizhong Wang, Wang Tianxiang, Cai Jialong, Lin Yanling, Lai Fubin, Peng Wentao, Xiaoping Wu*. An FGF8b-mimicking peptide with potent antiangiogenic activity. Molecular Medicine Reports. 2017, 16(1): 894-900.[3] Jizhong Wang, Xiangpeng Tan, Qi Yang, Xiangfeng Zeng, Yuying Zhou, Wu Luo, Xiaomian Lin, Li Song, Jialong Cai, Tianxiang Wang, Xiaoping Wu*. Inhibition of autophagy promotes apoptosis and enhances anticancer efficacy of adriamycin via augmented ROS generation in prostate cancer cells. The International Journal of Biochemistry & Cell Biology. 2016, 77(Pt A): 80-90.[4] Wu Luo, Li Song, Xilei Chen, Xiangfeng Zeng, Jianzhang Wu, Cairong Zhu, Tao Huang, Xiangpeng Tan, Xiaomian Lin, Qi Yang, Jizhong Wang, Xiaokun Li, Xiaoping Wu*. Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells. Oncotarget. 2016, 7(18): 26709-26723.[5] Tao Huang, Xiaomian Lin, Quchou Li, Wu Luo, Li Song, Xiangpeng Tan, Wenhui Wang, Xiaokun Li, Xiaoping Wu*. Selection of a novel FGF23-binding peptide antagonizing the inhibitory effect of FGF23 on phosphate uptake. Applied Microbiology and Biotechnology. 2015, 99(7): 3169-3177. [6] Lei Fan, Wulan Li, Shilong Ying, Lingyi Shi, Zhe Wang, Gaozhi Chen, Hui Ye, Xiaoping Wu*, Jianzhang Wu*, Guang Liang, Xiaokun Li. A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancer. Tumor Biology. 2015, 36(9): 7233-7241.[7] Wu Luo, Yonglin Yu, Ruixue Wang, Dan He, Cong Wang, Xiangfeng Zeng, Xilei Chen, Xiangpeng Tan, Tao Huang, Xiaoping Wu*. P7 peptides targeting bFGF sensitize colorectal cancer cells to CPT-11. International Journal of molecular medicine. 2014, 33(1): 194-200.

教育背景 :
1989.9～1993.6 四川大学 生物化学专业 获理学学士学位；1993.9～1996.6 中山大学 生物化学专业 获理学硕士学位；2004.9～2007.6 暨南大学 生物医学工程专业 获理学博士学位。